Jennifer Rountree
Jennifer Rountree has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Staci J. Wendt
Health Research Accelerator, Providence Research Network, Renton, WA, United States
2 shared publications - Alyson Caruso
Dana-Farber Cancer Institute, Boston, MA
1 shared publication - Ann Vita
Providence Health Research Accelerator, Renton, Washington
1 shared publication - Anna Revette
Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, United States
1 shared publication - Anton J. Bilchik
Department of Gastrointestinal and Hepatobiliary Surgery, Saint John’s Cancer Institute (SJCI), Saint John’s Health Center (SJHC), Providence Health System (PHS), Santa Monica, CA 90404, USA
1 shared publication - Brett Nava-Coulter
Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, United States
1 shared publication
Latest Publications
- Open Access
- 3 July 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e87037
Detecting and Preventing Fraudulent Participation in Qualitative Research: Content Analysis of Two Multisite Studies
Background: The use of web-based approaches to identify, recruit, enroll, survey, and interview health-related research participants has increased over time, with rapid acceleration since the COVID-19 pandemic. These approaches can make research more accessible to a broader population, but also increase the risk of fraudulent or imposter participants infiltrating research studies. While this threat has been discussed extensively in quantitative survey research, less has been reported in qualitative and mixed methods studies. Objective: This study aims to identify recurring patterns of fraudulent study participation and to offer strategies for identification, remediation, and reporting. Methods: Encounters with fraudulent or imposter individuals during recruitment, enrollment, survey distribution, data collection, and focus group sessions in 2 multisite qualitative and mixed methods research studies are presented. Content from both studies was analyzed to identify common themes and develop strategies for prevention and remediation. Results: Investigators across 2 multisite studies observed several indicators of suspected fraudulent activity, including large response volumes over a short period, highly repetitive email addresses, higher-than-expected proportions of phone numbers with area codes outside the study area, and unusual email/phone responses using atypical language and phrasing. Several imposter or fraudulent individuals disrupted online focus group sessions. To mitigate these issues, both studies implemented remediation strategies, including enhanced screening procedures at baseline, cross-checking of survey responses, and additional identity verification methods prior to participation. Studies took various actions to address these experiences, including notifying the institutional review board, recruitment platforms, and funders. Conclusions: This multisite study identified multiple ways that imposter or fraudulent participants can pose a significant and evolving threat to the integrity of qualitative and mixed methods. These types of fraudulent actors can distort data and undermine research credibility. Lessons learned highlight the importance of real-time recruitment and enrollment analysis and the need for transparent reporting. Addressing this issue will require a comprehensive approach to prevent and address fraudulent study participation that includes collaboration with multiple stakeholders and the broader research community to effectively address this issue.
- 3 July 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e87037
Open AccessDetecting and Preventing Fraudulent Participation in Qualitative Research: Content Analysis of Two Multisite Studies
Background: The use of web-based approaches to identify, recruit, enroll, survey, and interview health-related research participants has increased over time, with rapid acceleration since the COVID-19 pandemic. These approaches can make research more accessible to a broader population, but also increase the risk of fraudulent or imposter participants infiltrating research studies. While this threat has been discussed extensively in quantitative survey research, less has been reported in qualitative and mixed methods studies. Objective: This study aims to identify recurring patterns of fraudulent study participation and to offer strategies for identification, remediation, and reporting. Methods: Encounters with fraudulent or imposter individuals during recruitment, enrollment, survey distribution, data collection, and focus group sessions in 2 multisite qualitative and mixed methods research studies are presented. Content from both studies was analyzed to identify common themes and develop strategies for prevention and remediation. Results: Investigators across 2 multisite studies observed several indicators of suspected fraudulent activity, including large response volumes over a short period, highly repetitive email addresses, higher-than-expected proportions of phone numbers with area codes outside the study area, and unusual email/phone responses using atypical language and phrasing. Several imposter or fraudulent individuals disrupted online focus group sessions. To mitigate these issues, both studies implemented remediation strategies, including enhanced screening procedures at baseline, cross-checking of survey responses, and additional identity verification methods prior to participation. Studies took various actions to address these experiences, including notifying the institutional review board, recruitment platforms, and funders. Conclusions: This multisite study identified multiple ways that imposter or fraudulent participants can pose a significant and evolving threat to the integrity of qualitative and mixed methods. These types of fraudulent actors can distort data and undermine research credibility. Lessons learned highlight the importance of real-time recruitment and enrollment analysis and the need for transparent reporting. Addressing this issue will require a comprehensive approach to prevent and address fraudulent study participation that includes collaboration with multiple stakeholders and the broader research community to effectively address this issue.
- 16 December 2025
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (2) , 93-106
Uncovering the Red Flags: A Cross-Sectional Retrospective Case–Control Study on Predictors of Early-Onset Colorectal Cancer in a Multistate Community Health System
The increasing prevalence and aggressive, potentially fatal, nature of early-onset colorectal cancer (EOCRC) makes it critical to identify risk factors that can facilitate earlier screening and detection. With electronic medical record data, we compared adults ages 20 to 49 years diagnosed with EOCRC (2017–2023) to control patients without EOCRC who were 1:2 exact-matched based on age and sex. We extracted data on patients’ sociodemographics, comorbidities, hereditary syndromes, family history, symptoms, specialty visits, and medications within 12 to 24 months prior to or on their diagnostic visit. Using a model-building approach, we analyzed data with univariate then multivariate logistic regressions to predict the odds of EOCRC diagnosis. We constructed three models using high-risk background characteristics as predictors (baseline and high-risk) and exclusion criteria (sporadic), respectively. Our final analysis included 684 EOCRC cases and 1,368 controls. The mean age was 42 years, with 53% male, 72% White, and 72% non-Hispanic/Latino. Across all models, several predictors were significantly associated with higher EOCRC odds, including alcohol use history, higher number of comorbidities, abdominal pain, rectal bleeding, constipation, iron deficiency anemia, and prescriptions for metformin, non-steroidal anti-inflammatory drugs (NSAID), and multivitamins. Significant predictors of lower EOCRC odds were employment and Medicare/Medicaid insurance. By concurrently including symptoms, medical history, and sociodemographic characteristics, we constructed and validated well-fitting models with good discrimination that replicated and extended prior case–control research. To facilitate earlier screening and detection, these EOCRC risk factors can be used to identify patients who would benefit from screening earlier than 45 years of age. Prevention Relevance: There is a need for risk stratification models that simultaneously consider symptoms, medical history, and sociodemographic characteristics. This study identified a set of risk factors that can be used to recommend early screening to symptomatic and asymptomatic patients below the age of 45, even among those without high-risk familial background.
- 16 December 2025
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (2) , 93-106
Uncovering the Red Flags: A Cross-Sectional Retrospective Case–Control Study on Predictors of Early-Onset Colorectal Cancer in a Multistate Community Health System
The increasing prevalence and aggressive, potentially fatal, nature of early-onset colorectal cancer (EOCRC) makes it critical to identify risk factors that can facilitate earlier screening and detection. With electronic medical record data, we compared adults ages 20 to 49 years diagnosed with EOCRC (2017–2023) to control patients without EOCRC who were 1:2 exact-matched based on age and sex. We extracted data on patients’ sociodemographics, comorbidities, hereditary syndromes, family history, symptoms, specialty visits, and medications within 12 to 24 months prior to or on their diagnostic visit. Using a model-building approach, we analyzed data with univariate then multivariate logistic regressions to predict the odds of EOCRC diagnosis. We constructed three models using high-risk background characteristics as predictors (baseline and high-risk) and exclusion criteria (sporadic), respectively. Our final analysis included 684 EOCRC cases and 1,368 controls. The mean age was 42 years, with 53% male, 72% White, and 72% non-Hispanic/Latino. Across all models, several predictors were significantly associated with higher EOCRC odds, including alcohol use history, higher number of comorbidities, abdominal pain, rectal bleeding, constipation, iron deficiency anemia, and prescriptions for metformin, non-steroidal anti-inflammatory drugs (NSAID), and multivitamins. Significant predictors of lower EOCRC odds were employment and Medicare/Medicaid insurance. By concurrently including symptoms, medical history, and sociodemographic characteristics, we constructed and validated well-fitting models with good discrimination that replicated and extended prior case–control research. To facilitate earlier screening and detection, these EOCRC risk factors can be used to identify patients who would benefit from screening earlier than 45 years of age. Prevention Relevance: There is a need for risk stratification models that simultaneously consider symptoms, medical history, and sociodemographic characteristics. This study identified a set of risk factors that can be used to recommend early screening to symptomatic and asymptomatic patients below the age of 45, even among those without high-risk familial background.